Close Lucintel Chat
Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • Call Lucintel +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in Biomarker Market. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


The future of the global biomarker market looks promising with opportunities in diagnostic development, drug discovery & development, and disease risk applications. The global biomarker market is expected to grow with a CAGR of 11%-13% from 2020 to 2025. The major drivers for this market are increasing applications of biomarkers in diagnostics, increasing research and development activities in pharma and biotech companies, and increasing contract research organizations.
 

 
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global biomarker market report, please download the report brochure.
 
The study includes trends and forecast for the global biomarker market by product, type, disease indication, application, and region as follows:
 
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
  • Consumables
  • Services
By Type [Value ($ Million) shipment analysis for 2014 – 2025]:
  • Safety
  • Efficacy
  • Validation
By Disease Indication [Value ($ Million) shipment analysis for 2014 – 2025]:
  • Cancer
  • Cardiovascular Disorders
By Application [Value ($ Million) shipment analysis for 2014 – 2025]: 
  • Diagnostics Development
  • Drug Discovery and Development
  • Disease Risk
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
  • North America
  • United States
  • Canada 
  • Mexico
  • Europe
  • United Kingdom
  • Germany
  • France
  • Asia Pacific
  • China
  • India
  • Japan
  • The Rest of the World 
  • Brazil
Some of the biomarker companies profiled in this report include Qiagen, Perkinelmer, Merck Millipore, Bio-Rad Laboratories, Enzo Biochem, EKF Diagnostics, Meso Scale Diagnostics, Biosims Technologies, Cisbio Bioassays, and Signosis.
 
Lucintel forecasts that consumables will remain the largest product segment over the forecast period due to rising usage of reagent kits and assays for biomarker testing.
 
Within this market, cancer will remain the largest segment by disease indication over the forecast period due to increasing adoption of accurate and rapid diagnostic tools and rising demand for personalized medicines. 
 
North America will remain the largest region over the forecast period due to increasing prevalance of diseases, favorable government initiatives, and presence of major market players. These factors will contribute to biomarker-based drug discovery and development in the region. 
 
 
Features of the Global Biomarker Market
 
  • Market Size Estimates: Global biomarker market size estimation in terms of value ($M) shipment.
  • Trend and Forecast Analysis: Market trends (2014-2019) and forecast (2020-2025) by various segments.
  • Segmentation Analysis: Global biomarker market size by various segments, such as product, type, disease indication, and application, in terms of value.
  • Regional Analysis: Global biomarker market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different products, types, disease indications, applications, and regions for the global biomarker market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the global biomarker market.
  • Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
 
 
 
This report answers following key questions
 
Q.1 What are some of the most promising potential, high-growth opportunities for the global biomarker market by product (consumables and service), type (safety, efficacy, and validation), disease indication (cancer and cardiovascular disorders), application (diagnostics development, drug discovery & development, and disease risk), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q.2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global biomarker market?
Q.5 What are the business risks and threats to the global biomarker market?
Q.6 What are the emerging trends in this biomarker market and the reasons behind them?
Q.7 What are some changing demands of customers in this biomarker market?
Q.8 What are the new developments in this biomarker market? Which companies are leading these developments?
Q.9 Who are the major players in this biomarker market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this biomarker market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M&A activities did take place in the last five years in the global biomarker market?

 
 
Report Scope

Key Features Description
Base Year for Estimation 2019
Trend Period
(Actual Estimates)		 2014-2019
Forecast Period 2020-2025
Pages More than 150
Market Representation / Units Revenue in US $ Million
Report Coverage Market Trends & Forecast, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling
Market Segments Product (Consumables and Service), Type (Safety, Efficacy, and Validation), Disease Indication (Cancer and Cardiovascular Disorders), and Application (Diagnostics Development, Drug Discovery and Development, and Disease Risk)

Regional Scope

North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil)
Customization 10% Customization without Any Additional Cost

Table of Contents
 
1. Executive Summary
 
2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
 
3. Market Trends and Forecast Analysis from 2014 to 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Biomarker Market Trends and Forecast
3.3: Global Biomarker Market by Product
3.3.1: Consumables
3.3.2: Services
3.4: Global Biomarker Market by Type
3.4.1: Safety 
3.4.2: Efficacy
3.4.3: Validation
3.5: Global Biomarker Market by Disease Indication
3.5.1: Cancer
3.5.2: Cardiovascular Disorders
3.6: Global Biomarker Market by Application
3.6.1: Diagnostics Development
3.6.2: Drug Discovery and Development
3.6.3: Disease Risk
 
4. Market Trends and Forecast Analysis by Region
4.1: Global Biomarker Market by Region
4.2: North American Biomarker Market
4.2.1: Market by Product: Consumables and Service
4.2.2: Market by Type: Safety, Efficacy, and Validation 
4.2.3: Market by Disease Indication: Cancer and Cardiovascular Disorders 
4.2.4: Market by Application: Diagnostics Development, Drug Discovery and Development, and Disease Risk 
4.2.5: The United States Biomarker Market
4.2.6: The Canadian Biomarker Market
4.2.7: The Mexican Biomarker Market
4.3: European Biomarker Market
4.3.1: Market by Product: Consumables and Service 
4.3.2: Market by Type: Safety, Efficacy, and Validation 
4.3.3: Market by Disease Indication: Cancer and Cardiovascular Disorders 
4.3.4: Market by Application: Diagnostics Development, Drug Discovery and Development, and Disease Risk 
4.3.5: The Biomarker Market of the United Kingdom
4.3.6: The German Biomarker Market
4.3.7: The French Biomarker Market
4.4: APAC Biomarker Market
4.4.1: Market by Product: Consumables and Service 
4.4.2: Market by Type: Safety, Efficacy, and Validation 
4.4.3: Market by Disease Indication: Cancer and Cardiovascular Disorders 
4.4.4: Market by Application: Diagnostics Development, Drug Discovery and Development, and Disease Risk 
4.4.5: The Chinese Biomarker Market
4.4.6: The Indian Biomarker Market
4.4.7: The Japanese Biomarker Market
4.5: ROW Biomarker Market
4.5.1: Market by Product: Consumables and Service 
4.5.2: Market by Type: Safety, Efficacy, and Validation 
4.5.3: Market by Disease Indication: Cancer and Cardiovascular Disorders 
4.5.4: Market by Application: Diagnostics Development, Drug Discovery and Development, and Disease Risk 
4.5.5: Brazilian Biomarker Market
 
5. Competitor Analysis
5.1: Market Share Analysis
5.2: Product Portfolio Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
 
6. Cost Structure Analysis
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
 
7. Growth Opportunities and Strategic Analysis
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Biomarker Market by Product 
7.1.2: Growth Opportunities for the Global Biomarker Market by Type
7.1.3: Growth Opportunities for the Global Biomarker Market by Disease Indication
7.1.4: Growth Opportunities for the Global Biomarker Market by Application
7.1.5: Growth Opportunities for the Global Biomarker Market by Region
7.2: Emerging Trends in the Global Biomarker Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Biomarker Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biomarker Market
7.3.4: Certification and Licensing
 
8. Company Profiles of Leading Players
8.1: Qiagen N.V. 
8.2: Perkinelmer, Inc. 
8.3: Merck Millipore
8.4: Bio-Rad Laboratories, Inc.
8.5: Enzo Biochem, Inc. 
8.6: EKF Diagnostics Holdings, Inc. 
8.7: Meso Scale Diagnostics, LLC. 
8.8: Biosims Technologies Sas
8.9: Cisbio Bioassays
8.10: Signosis, Inc.
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Biomarker Market: Trends, Forecast and Competitive Analysis Full Report $ 4,850
150 - page report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data 
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
 
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process. 
 

Please sign in below to get report brochure - Biomarker Market.

At Lucintel, we respect your privacy and maintain the confidentiality of information / data provided by you
(Please enter your corporate email. * These fields are mandatory )
Have an Account / Returning Visitors?

Follow us on